|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7072 | |
| A61K 31/4188 | |||
| A61K 9/16 | |||
| A61K 9/20 |
| (11) | Number of the document | 3038601 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14704501.7 |
| Date of filing the European patent application | 2014-01-30 | |
| (97) | Date of publication of the European application | 2016-07-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/013930 |
| Date | 2014-01-30 |
| (87) | Number | WO 2015/030853 |
| Date | 2015-03-05 |
| (30) | Number | Date | Country code |
| 201361870712 P | 2013-08-27 | US | |
| 201361898690 P | 2013-11-01 | US | |
| 201361907308 P | 2013-11-21 | US |
| (72) |
GORMAN, Eric, US
MOGALIAN, Erik, US
OLIYAI, Reza, US
STEFANIDIS, Dimitrios, US
WISER, Lauren, US
ZIA, Vahid, US
|
| (73) |
Gilead Pharmasset LLC,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS |
| COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS |